ArrowArtboardCreated with Sketch.Title ChevronTitle ChevronIcon FacebookIcon LinkedinIcon Mail ContactPath LayerIcon MailPositive ArrowIcon Print

Temasek and Jack Ma fund lead $75m round for Chinese genomic company

Singapore state investor and Alibaba founder back big data for medical R&D

Singapore state investor Temasek is betting on the use of big data and smart technology in the medical sector.

SINGAPORE -- Singaporean state investor Temasek Holdings and private equity firm Yunfeng Capital, backed by Chinese e-commerce group Alibaba's founder Jack Ma, have led a $75 million funding round for WuXi NextCODE, a Chinese genomics data company.

According to an announcement from the genomics company on Tuesday, other investors in the fundraising include Amgen Ventures, the U.S. biotechnology group's venture capital fund, and 3W Partners, a private equity firm focused on greater China and cross-border deals.

Sponsored Content

About Sponsored Content This content was commissioned by Nikkei's Global Business Bureau.

Nikkei Asian Review, now known as Nikkei Asia, will be the voice of the Asian Century.

Celebrate our next chapter
Free access for everyone - Sep. 30

Find out more